Skip to main content
. 2021 Jun 12;7:292–323. doi: 10.1016/j.bioactmat.2021.05.038

Fig. 3.

Fig. 3

Typical polymers used for TOs delivery. (a) Natural–origin polymers-based NPs; (b) Synthetic polymers-based NPs; (c) Chitosan-hyaluronic acid dialdehyde nanoparticles (CS-HAD-NPs) for Bcl-2 siRNA delivery in the application of bladder cancer therapy [180]. Copyright 2021, Elsevier B.V.; (d) Schematic of core-shell structure based nanoparticles for drug delivery [181]. Copyright 2019, United States National Academy of Sciences.